Balloon Elution and Late Loss Optimization (BELLO) Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 182 participants.

Also called NCT01086579

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 182 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01086579
Other papers using this trial's data
  • A randomized multicenter study comparing a paclitaxel drug-eluting balloon with a paclitaxel-eluting stent in small coronary vessels: the BELLO (Balloon Elution and Late Loss Optimization) study Journal of the American College of Cardiology, 2012-12-18 DOI, PubMed 23158530

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Italy (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01086579. Randomized; no masking; primary purpose treatment. Start 2010-03 (registry gives no type); primary completion 2012-03 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Balloon Elution and Late Loss Optimization (BELLO) Study
Acronym
BELLO
Intervention (Device)
IN.PACT Falcon paclitaxel eluting balloon (Drug eluting balloon)
Intervention (Device)
Taxus (Paclitaxel eluting stent)
Lead sponsor
Fondazione Evidence per Attività e Ricerche Cardiovascolari ONLUS (class: other)

Record details

Record id
cardio:ct-nct01086579
Content hash
43f19ff8929adf46dcbbcb1e9ade07008ca3ada23c3290a29e0d611b2108a4ae